Virulence shifts of Candida albicans biofilms induced by ethinylestradiol/drospirenone contraceptive

Detalhes bibliográficos
Autor(a) principal: Rosa, Edvaldo
Data de Publicação: 2022
Outros Autores: Rymovicz, Alinne, Selow, Marcela, Oliveira, Nicoly, Rosa, Rosimeire, Campelo, Patrícia, Bianchini, Luiz, Hardy, Ana
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/329
Resumo: It is estimated that approximately 167 million women worldwide use combined oral contraceptive (COC). In United States, products containing ethinylestradiol plus drospirenone (EE+DRSP) moved about US$ 616 million in 2008. There is evidence that contraceptives increase the virulence of Candida albicans. However, modulation of fungal virulence by drospirenone-containing COC remains unknown. The objective of this study was to evaluate whether virulence factors are increased when C. albicans is exposed to EE+DRSP. The ATCC®90028™, SC5314 and 15A2 strains were grown in the presence of EE+DRSP at 10 nM:10 μM, 50 nM:50 μM, and 100 nM:100 μM under continuous flow in a dedicated bioreactor for biofilm growth. 72-h biofilms were evaluated in relation to their proteolytic capacities, biomass production (MTT reduction assay), and induction of germ-tube formation and measurements of agar invasion. Only 50 nM:50 μM EE+DRSP caused reductions in biomass (p=0.023); the other did not promote any change (p>0.05). The contraceptive exposure was insufficient to cause any increase in germ tubes induction (p>0.05). There was a concentration-dependent increment in the hyphae invasiveness. On the other hand, the proteolytic activity increased in a concentration- dependent manner (p<0.01). When exposed to EE+DRSP, Candida albicans strains do not form greater amounts of biofilm, neither generate more germ tubes, nor become more invasive; however, they secrete greater quantities of proteases, which facilitate the adhesion and invasion of tissue.
id RCAP_91433c6706629d950a4cd5c5280a7062
oai_identifier_str oai:ojs.actafarmaceuticaportuguesa.com:article/329
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Virulence shifts of Candida albicans biofilms induced by ethinylestradiol/drospirenone contraceptiveIt is estimated that approximately 167 million women worldwide use combined oral contraceptive (COC). In United States, products containing ethinylestradiol plus drospirenone (EE+DRSP) moved about US$ 616 million in 2008. There is evidence that contraceptives increase the virulence of Candida albicans. However, modulation of fungal virulence by drospirenone-containing COC remains unknown. The objective of this study was to evaluate whether virulence factors are increased when C. albicans is exposed to EE+DRSP. The ATCC®90028™, SC5314 and 15A2 strains were grown in the presence of EE+DRSP at 10 nM:10 μM, 50 nM:50 μM, and 100 nM:100 μM under continuous flow in a dedicated bioreactor for biofilm growth. 72-h biofilms were evaluated in relation to their proteolytic capacities, biomass production (MTT reduction assay), and induction of germ-tube formation and measurements of agar invasion. Only 50 nM:50 μM EE+DRSP caused reductions in biomass (p=0.023); the other did not promote any change (p>0.05). The contraceptive exposure was insufficient to cause any increase in germ tubes induction (p>0.05). There was a concentration-dependent increment in the hyphae invasiveness. On the other hand, the proteolytic activity increased in a concentration- dependent manner (p<0.01). When exposed to EE+DRSP, Candida albicans strains do not form greater amounts of biofilm, neither generate more germ tubes, nor become more invasive; however, they secrete greater quantities of proteases, which facilitate the adhesion and invasion of tissue.Acta Farmacêutica Portuguesa2022-12-24info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://actafarmaceuticaportuguesa.com/index.php/afp/article/view/329Acta Farmacêutica Portuguesa; v. 11 n. 2 (2022): Acta Farmacêutica Portuguesa; 61-692182-3340reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://actafarmaceuticaportuguesa.com/index.php/afp/article/view/329https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/329/258Rosa, EdvaldoRymovicz, AlinneSelow, MarcelaOliveira, NicolyRosa, RosimeireCampelo, PatríciaBianchini, LuizHardy, Anainfo:eu-repo/semantics/openAccess2022-12-30T17:00:27Zoai:ojs.actafarmaceuticaportuguesa.com:article/329Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:29:07.070377Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Virulence shifts of Candida albicans biofilms induced by ethinylestradiol/drospirenone contraceptive
title Virulence shifts of Candida albicans biofilms induced by ethinylestradiol/drospirenone contraceptive
spellingShingle Virulence shifts of Candida albicans biofilms induced by ethinylestradiol/drospirenone contraceptive
Rosa, Edvaldo
title_short Virulence shifts of Candida albicans biofilms induced by ethinylestradiol/drospirenone contraceptive
title_full Virulence shifts of Candida albicans biofilms induced by ethinylestradiol/drospirenone contraceptive
title_fullStr Virulence shifts of Candida albicans biofilms induced by ethinylestradiol/drospirenone contraceptive
title_full_unstemmed Virulence shifts of Candida albicans biofilms induced by ethinylestradiol/drospirenone contraceptive
title_sort Virulence shifts of Candida albicans biofilms induced by ethinylestradiol/drospirenone contraceptive
author Rosa, Edvaldo
author_facet Rosa, Edvaldo
Rymovicz, Alinne
Selow, Marcela
Oliveira, Nicoly
Rosa, Rosimeire
Campelo, Patrícia
Bianchini, Luiz
Hardy, Ana
author_role author
author2 Rymovicz, Alinne
Selow, Marcela
Oliveira, Nicoly
Rosa, Rosimeire
Campelo, Patrícia
Bianchini, Luiz
Hardy, Ana
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Rosa, Edvaldo
Rymovicz, Alinne
Selow, Marcela
Oliveira, Nicoly
Rosa, Rosimeire
Campelo, Patrícia
Bianchini, Luiz
Hardy, Ana
description It is estimated that approximately 167 million women worldwide use combined oral contraceptive (COC). In United States, products containing ethinylestradiol plus drospirenone (EE+DRSP) moved about US$ 616 million in 2008. There is evidence that contraceptives increase the virulence of Candida albicans. However, modulation of fungal virulence by drospirenone-containing COC remains unknown. The objective of this study was to evaluate whether virulence factors are increased when C. albicans is exposed to EE+DRSP. The ATCC®90028™, SC5314 and 15A2 strains were grown in the presence of EE+DRSP at 10 nM:10 μM, 50 nM:50 μM, and 100 nM:100 μM under continuous flow in a dedicated bioreactor for biofilm growth. 72-h biofilms were evaluated in relation to their proteolytic capacities, biomass production (MTT reduction assay), and induction of germ-tube formation and measurements of agar invasion. Only 50 nM:50 μM EE+DRSP caused reductions in biomass (p=0.023); the other did not promote any change (p>0.05). The contraceptive exposure was insufficient to cause any increase in germ tubes induction (p>0.05). There was a concentration-dependent increment in the hyphae invasiveness. On the other hand, the proteolytic activity increased in a concentration- dependent manner (p<0.01). When exposed to EE+DRSP, Candida albicans strains do not form greater amounts of biofilm, neither generate more germ tubes, nor become more invasive; however, they secrete greater quantities of proteases, which facilitate the adhesion and invasion of tissue.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-24
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/329
url https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/329
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/329
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/329/258
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Acta Farmacêutica Portuguesa
publisher.none.fl_str_mv Acta Farmacêutica Portuguesa
dc.source.none.fl_str_mv Acta Farmacêutica Portuguesa; v. 11 n. 2 (2022): Acta Farmacêutica Portuguesa; 61-69
2182-3340
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130749014638592